Medical Devices Australia

Australia Biosensors Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Australia Biosensors Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $393.0 Mn Placeholder estimate
Estimate 2025 $431.9 Mn 1.3% of the global market
Projected 2034 $1.01 Bn 133.9% Adds $578.2 Mn over 9 forecast years
CAGR 2025–2034 9.9% Faster than 47% of 173 Medical Devices markets here
Key players 5
  • Australia is 1.32% of the global market.
  • In APAC, the largest is China at $2.81 Bn.
  • Fastest growing: India at 11.1% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$578.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Biosensors Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $393.0 Mn — —
2025 (base) $431.9 Mn +$38.9 Mn —
2026 (forecast) $474.7 Mn +$42.8 Mn +9.9%
2027 (forecast) $521.7 Mn +$47.0 Mn +20.8%
2028 (forecast) $573.3 Mn +$51.6 Mn +32.7%
2029 (forecast) $630.1 Mn +$56.8 Mn +45.9%
2030 (forecast) $692.4 Mn +$62.4 Mn +60.3%
2031 (forecast) $761.0 Mn +$68.6 Mn +76.2%
2032 (forecast) $836.3 Mn +$75.3 Mn +93.6%
2033 (forecast) $919.1 Mn +$82.8 Mn +112.8%
2034 (forecast) $1.01 Bn +$91.0 Mn +133.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia Biosensors Market Analysis at a glance
Market size, 2025$431.9 Mn placeholder estimate
Forecast, 2034$1.01 Bn placeholder estimate
Growth (CAGR), 2025–20349.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType and application (see all)
Key playersAbbott Laboratories, Medtronic, Dexcom, Inc., Roche, Siemens Healthineers (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Biosensors Market Analysis Executive Summary

Biosensors are devices that detect biological signals such as glucose, lactate or heart activity and turn them into data.

Key segments of the biosensors market include type (Electrochemical, Optical and Piezoelectric) and application (Medical, Food Testing and Environmental).

Bar chart: Australia Biosensors market size, 2024–2034, placeholder estimates. $393.0 Mn in 2024, $431.9 Mn in 2025 and $1.01 Bn in 2034, 9.9% CAGR.
Australia Biosensors market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Biosensors Market Dynamics

Market Growth Drivers

Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the biosensors market. Doctors are starting to use wearable data in care decisions.

Opportunity

Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the biosensors market strong growth.

Market Restraints

Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the biosensors market.

Competitive Landscape for Biosensors Market in Australia

The biosensors market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Biosensors Market in Australia

Biosensors in Australia: rules and payment

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how biosensors products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Biosensors right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Biosensors in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Biosensors market in Australia?
Placeholder estimate: about $431.9 Mn in 2025, rising to about $1.01 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Biosensors market in Australia growing?
Placeholder estimate: about 9.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Biosensors market report cover?
The report splits the market by type (Electrochemical, Optical, Piezoelectric, Thermal) and application (Medical, Food Testing, Environmental, Research).
Who are the key players in the Biosensors market?
Key players include Abbott Laboratories, Medtronic, Dexcom, Inc., Roche and Siemens Healthineers.
What is driving the Biosensors market?
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the biosensors market. Doctors are starting to use wearable data in care decisions.
Who regulates Biosensors in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How much research is published on Biosensors?
PubMed lists 15,962 papers on Biosensors added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Australia

See all

Related on diagnostics and lab testing and remote monitoring and wearables

See the topic